http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Simulations Plus to Present at the LD 500 Virtual Conference
-
Simulations Plus Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Simulations Plus (SLP) Prices 1.818M Share Common Offering at $55/Sh
-
Simulations Plus Announces Pricing of $100 Million Underwritten Offering of Common Stock
-
Simulations Plus (SLP) Announces Proposed Underwritten Public Offering of Common Stock
-
Simulations Plus Announces Proposed Underwritten Public Offering
-
Simulations Plus Reports Third Quarter FY2020 Financial Results
-
Simulations Plus Sets Date for 3rd Quarter 2020 Earnings Release and Conference Call
-
Simulations Plus (SLP) Receives New Grant Award from the FDA
-
Simulations Plus Receives New Grant Award from the FDA
-
Simulations Plus to Present at 17th Annual Craig-Hallum Institutional Investor Conference
-
Simulations Plus to Present at 15th Annual Needham Virtual Technology & Media Conference
-
U.S. FDA Renews Annual DILIsym Software Licenses
-
Simulations Plus Reports Record Second Quarter FY2020 Revenue
-
Simulations Plus (SLP) Partners with Large Pharmaceutical Company to Advance ADMET Predictor Machine Learning Software
-
Simulations Plus Partners with Large Pharmaceutical Company to Enhance High-Throughput PBPK Capabilities in ADMET Predictor®
-
Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call
-
Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe
-
Simulations Plus (SLP) Offers Rapid Response COVID-19 Research Initiative
-
Simulations Plus Offers Rapid Response COVID-19 Research Initiative
-
Sandra Suarez-Sharp Joins Simulations Plus to Lead Regulatory Strategies Team
-
DILIsym Services Partners with Large Pharmaceutical Company to Begin QSP Model Development for Heart Failure
-
Simulations Plus to Present at the 22nd Annual Needham Growth Conference
-
Simulations Plus Reports Record First Quarter FY2020 Financial Results
-
Simulations Plus Sets Date for First Quarter Fiscal Year 2020 Earnings Release and Conference Call
-
Simulations Plus Partners with Bayer AG to Develop New Cheminformatics Capabilities in ADMET Predictor
-
Simulations Plus Partners with Large Pharmaceutical Company to Add New Capabilities to PKPlus
-
Simulations Plus Partners with Large Pharmaceutical Company to Enhance the Mechanistic Oral Absorption (ACAT) Model in GastroPlus
-
Simulations Plus Reports FY2019 and Fourth Quarter FY2019 Financial Results
-
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2019 Earnings Release and Conference Call
-
Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module
-
Simulations Plus Partners with Clinical-Stage Biotech Company to Develop Novel Dosing Models
-
UPDATE: Simulations Plus (SLP) Announces New Research Collaboration Agreement with FDA
-
Simulations Plus Enters into New Research Collaboration Agreement with the FDA
-
Simulations Plus Reports Third Quarter FY2019 Financial Results
-
Simulations Plus Upgrades PKPlus™
-
Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call
-
Simulations Plus Upgrades Flagship GastroPlus
-
Cognigen Launches KIWI Version 4.0
-
PMDA Adds Licenses of GastroPlus®
-
U.S. FDA Renews DILIsym Software Licenses
-
Simulations Plus to Present at B. Riley FBR Investor Conference on May 22, 2019
-
Simulations Plus (SLP) Appoints Lisa LaVange PhD to Board
-
Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus
-
Simulations Plus (SLP) Secures 15-User License Purchase from FDA for ADMET Predictor Software Suite
-
FDA Purchases Bundle of ADMET Predictor® Licenses
-
Simulations Plus Releases ADMET Predictor® Version 9.5
-
Simulations Plus Reports Record Second Quarter FY2019 Revenue
-
Simulations Plus Releases DDDPlus™ Version 6
-
Simulations Plus to Present at the 21st Annual Needham Growth Conference

